ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disability"

  • Abstract Number: 1089 • 2014 ACR/ARHP Annual Meeting

    Trajectories of Disability over Time Among Patients with Systemic Sclerosis

    Sarah D. Mills1, Rina S. Fox1, Shadi Gholizadeh2, Scott C. Roesch1,3, Murray Baron4,5, Marie Hudson6,7, Russell Steele6,8, Brett D. Thombs6,9 and Vanessa L. Malcarne1,10, 1SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2Psychology, SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, 3Psychology, San Diego State University, San Diego, CA, 4Pavillion A, Rm 216, Jewish General Hospital, Montreal, QC, Canada, 5McGill University, Montreal, QC, Canada, 6Jewish General Hospital, Montreal, QC, Canada, 7Division of Rheumatology, McGill University, Montreal, QC, Canada, 8Mathematics, McGill University, Montreal, QC, Canada, 9Psychiatry, McGill University, Montreal, QC, Canada, 10San Diego State University, San Diego, CA

    Background/Purpose Systemic Sclerosis (SSc) is often associated with disability, which worsens over time. However, there is considerable heterogeneity in the rate of patients’ disability progression.…
  • Abstract Number: 2975 • 2014 ACR/ARHP Annual Meeting

    Residual Large Joint Synovitis By Power Doppler Ultrasonography Is Associated with Higher Disease Activity and Significant Impact of Disease in Multi-Ethnic Asian Patients with Established Rheumatoid Arthritis

    Yu Xiao Guo1, Manjari Lahiri2,3 and Peter Cheung2,3, 1Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, 2Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, 3Division of Rheumatology, National University Hospital, Singapore, Singapore

    Background/Purpose Regular monitoring of disease activity with appropriate modification of disease-modifying anti-rheumatic drug (DMARD) therapy results in improved radiographic and functional outcomes in patients with…
  • Abstract Number: 2944 • 2014 ACR/ARHP Annual Meeting

    Sedentary Time Is an Independent Risk Factor for Disability Onset Among Adults at Elevated Risk: Prospective Cohort Study

    Jungwha Lee1, Jing Song2, Barbara Ainsworth3, Rowland W. Chang4, Linda S. Ehrlich-Jones5, Christine Pellegrini6, Pamela Semanik7, Dorothy D. Dunlop2 and Leena Sharma8, 1Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Arizona State University, Pheonix, AZ, 4Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Rehabilitation Institute of Chicago, Chicago, IL, 6Center for Behavioral Health, Northwestern University Feinberg School of Medicine, Chicago, IL, 7Rush University, Chicago, IL, 8Northwestern University, Chicago, IL

    Background/Purpose:  Disability threatens personal independence and is a major driver of health care costs. Physical activity has been shown to prevent disability.  Sedentary behavior, already…
  • Abstract Number: 2525 • 2014 ACR/ARHP Annual Meeting

    Infliximab Versus Conventional Combination Treatment and Work Loss in Early RA over 7 Years: A Randomized Trial

    Jonas K Eriksson1, Heather Miller2, Johan A Karlsson3, Ingemar F Petersson4, Sofia Ernestam5, Pierre Geborek3, Ronald F van Vollenhoven2 and Martin Neovius1, 1Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 2ClinTRID, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 3Section of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, 4Section of Orthopedics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, 5Department of Learning, Informatics and Medical Education (LIME), Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: The introduction of TNF inhibitors has improved the treatment of RA, but at a substantial cost. The randomized Swefot trial compared the addition of…
  • Abstract Number: 2273 • 2014 ACR/ARHP Annual Meeting

    Does a Standardized Multidisciplinary Approach Improve Outcomes for Children with NMDA Receptor Antibody Encephalitis? : A Preliminary Assessment of a Single Center Experience

    Mered Parnes1, Amber Stocco2, Trung Nguyen3, Jun Teruya4, Jeanine Graf3 and Eyal Muscal5, 1Child Neurology, Baylor College of Medicine, Houston, TX, 2Integris Pediatric Neurology, Oklahoma City, OK, 3Pediatrics-critical care, Baylor College of Medicine, Houston, TX, 4Pathology, Baylor College of Medicine, Houston, TX, 5Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Houston, TX

    Background/Purpose: NMDA receptor antibody encephalitis (NMDAR) is a potentially devastating isolated autoimmune condition affecting children and young adults that was mostly unrecognized prior to 2007.…
  • Abstract Number: 124 • 2013 ACR/ARHP Annual Meeting

    Disability In Fibromyalgia Is Associated With Greater Self-Reported Symptoms and Functional Impairment

    Emmanouil Rampakakis1,2, Mary-Ann Fitzcharles3, Peter A. Ste-Marie4, John S. Sampalis1,2 and Yoram Shir4, 1JSS Medical Research, Montreal, QC, Canada, 2Jewish General Hospital, McGill University, Montreal, QC, Canada, 3Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 4Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: It is intuitive that disablement due to illness should be reflected in illness severity. When illness measurement is based on subjective report only, without…
  • Abstract Number: 2292 • 2013 ACR/ARHP Annual Meeting

    Factors Affecting The Discrepancy Between Physician and Patient Global Assessment Of Disease Activity In Early and Established Rheumatoid Arthritis Patients- Results From The Ontario Best Practices Initiative

    Pooneh Akhavan1, Binu Jacob2, Edward C. Keystone3,4, Xiuying Li5, J. Carter Thorne6 and Claire Bombardier7, 1Medicine, Early Rheumatoid Arthritis Program, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, 2University Health Network, Toronto General Research Institute, Toronto, ON, Canada, 3Rebecca MacDonald Centre for Arthritis and Autoimmune Disease, Mount Sinai Hospital, Toronto, ON, Canada, 4University of Toronto/Mount Sinai Hospital, Toronto, ON, Canada, 5Clinical Decision Making and Health Care, University Health Network, Toronto, ON, Canada, 6Southlake Regional Health Centre, Newmarket, ON, Canada, 7Rheumatology, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Discrepancy between patient (PGA) and physician (MDGA) global assessments in Rheumatoid Arthritis (RA) can adversely affect therapeutic decisions. The pattern of PGA and MDGA,…
  • Abstract Number: 2090 • 2013 ACR/ARHP Annual Meeting

    The Effects of Commercially Available Footwear On Foot Pain and Disability in People With Gout: A Feasibility Study

    Keith Rome1, Sarah Stewart2, Alain Vandal3,4, Peter J. Gow5, Peter J. McNair2 and Nicola Dalbeth6, 1Health & Rehabilitation Research Institute, Auckland, New Zealand, AUT University, Auckland, New Zealand, 2Health & Rehabilitation Research Institute, AUT University, Auckland, New Zealand, 3Faculty of Health and Environmental Sciences, AUT University, Auckland, New Zealand, 4Counties Manukau District Health Board, Auckland, New Zealand, 5Rheumatology Dept, Middlemore Hospital, Auckland, New Zealand, 6Medicine, University of Auckland, Auckland, New Zealand

    Background/Purpose: The non-pharmacological management goals for people with foot-related rheumatic diseases are pain management, preservation of foot function and patient mobility. One of the therapeutic…
  • Abstract Number: 1989 • 2013 ACR/ARHP Annual Meeting

    Determinants Of Functional Disability In Patients With Gout: Longitudinal Analysis From a Multicentre Observational Study Of The Italian Society For Rheumatology

    Carlo Alberto Scirè1, Maria Manara1, Greta Carrara1, Marco A. Cimmino2, Marcello Govoni3, Fausto Salaffi4, Leonardo Punzi5, Carlomaurizio Montecucco6, Marco Matucci-Cerinic7 and Giovanni Minisola8, 1Epidemiology Unit -Italian Society for Rheumatology, Milano, Italy, 2Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, 3Clinical and Experimental Medicine, Section of Rheumatology, University of Ferrara, Ferrara, Italy, 4Rheumatology Unit - Polytechnic University of the Marche, Jesi, Italy, 5Department of Medicine - DIMED, University of Padova, Padova, Italy, 6Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy, 7Rheumatology, University of Florence, Azienda Ospedaliera Careggi, Florence, Italy, 8Rheumatology Unit, San Camillo-Forlanini Hospital, Rome, Italy

    Background/Purpose: Gout is the most prevalent arthritis and significantly impacts on function. Beside the influence of concurrent comorbidities, identifying disease-related prognostic factors may help to…
  • Abstract Number: 1791 • 2013 ACR/ARHP Annual Meeting

    Reaching The Target Of Low Disease Activity At 6 Months Predicts Better Long-Term Functional Outcome In Patients With Early Rheumatoid Arthritis

    Pooneh Akhavan1, Bindee Kuriya2, Edward C. Keystone3,4, Juan Xiong5, Janet E. Pope6, Gilles Boire7, Diane Tin8, Boulos Haraoui9, Carol A. Hitchon10 and Vivian P. Bykerk11,12, 1Medicine, Early Rheumatoid Arthritis Program, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, 2Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 3Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 4Rebecca MacDonald Centre for Arthritis and Autoimmune Disease, Mount Sinai Hospital, Toronto, ON, Canada, 5Mount Sinai Hospital, Toronto, ON, Canada, 6St Joseph Health Care, London, ON, Canada, 7Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, 8The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 9Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada, 10Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 11Medicine, Mount Sinai Hospital/University of Toronto, Toronto, ON, Canada, 12Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY

    Background/Purpose: Current clinical practice guidelines recommend remission, and if not possible, low disease activity (LDA) as the treatment target in rheumatoid arthritis (RA).  Patients should…
  • Abstract Number: 1779 • 2013 ACR/ARHP Annual Meeting

    A Randomized Controlled, Clinical, Histological and mRNA Profiling Pilot Study Of Endurance Exercise In Myositis

    Li Alemo Munters1,2, Ingela M. Loell3, Joan Raouf4, Maryam Dastmalchi3, Eva Lindroos5, Christina Ottosson6, Yi-Wen Chen7, Annemarie F van Delden8, Mona Esbjörnsson9, Marina Korotkova10, Helene Alexanderson11, Kanneboyina Nagaraju12 and Ingrid E. Lundberg13, 1Department of Medicine, Rheumatology Unit, , Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, 2Department of Physiotherapy, Rheumatology Unit, Karolinska University Hospital in Solna, Stockholm, Sweden, Stockholm, Sweden, 3Rheumatology Unit, Department of Medicine, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, 4Department of Medicine, Rheumatology Unit, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 5Department of Medicine, Rheumatology Unit, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden., Stockholm, Sweden, 6Department of Medicine, Rheumatology Unit, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden., Stockholm, Sweden, 7Research Center for Genetic Medicine, Children’s National Medical Center, Washington DC, USA., Washington DC, DC, 8Department of Medicine,, Rheumatology Unit, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden., Stockholm, Sweden, 9Department of Physiology, Karolinska Institutet, Huddinge, Sweden, 10Department of Medicine, Rheumatology Unit, Department of Medicine, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 11Department of Neurobiology, Care Science and Society, Division of Physiotherapy, Division of Physiotherapy, Karolinska Institutet, Huddinge, Stockholm, Sweden, 12Research Center for Genetic Medicine, Children’s National Medical Center, Washington DC, DC, 13Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: This pilot study is a hypothesis-driven exploratory part of a larger randomized controlled trial evaluating effects of a supervised 12-week endurance exercise program (EG)…
  • Abstract Number: 1306 • 2013 ACR/ARHP Annual Meeting

    Do Sustained Clinical Remission and Sustained Low Disease Activity Equally Predict Functional Status In Early Rheumatoid Arthritis?

    Bindee Kuriya1, Juan Xiong2, Gilles Boire3, Boulos Haraoui4, Carol A. Hitchon5, Janet E. Pope6, J. Carter Thorne7, Diane Tin8, Edward C. Keystone9, Cheryl Barnabe10, Pooneh Akhavan11 and Vivian P. Bykerk12, 1Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 2Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 3Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, 4Rheumatology, Institut de Rhumatologie de Montréal, Montreal, QC, Canada, 5University of Manitoba, Winnipeg, MB, Canada, 6Rheumatology, St Joseph Health Centre, London, ON, Canada, 7Southlake Regional Health Centre, Newmarket, ON, Canada, 8The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 9Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 10Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, 11Medicine, Early Rheumatoid Arthritis Program, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, 12Divison of Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose:   Sustained clinical remission (REM) is the therapeutic goal in rheumatoid arthritis (RA) but low disease activity (LDA) may be acceptable.  Little is known…
  • Abstract Number: 250 • 2013 ACR/ARHP Annual Meeting

    Synovial Inflammation In Meniscal Tear Patients: CCL19 mRNA Expression Is Independently Associated With Knee Related Disability

    Anjali Nair1, Charles Bush-Joseph2, Nikhil Verma2, Matthew Tetreault2, Kanta Saha3, Arkady Margulis4, Louis F. Fogg5 and Carla R. Scanzello3, 1Section of Rheumatology, Rush University Medical Center, Chicago, IL, 2Orthopedics, Rush University Medical Center, Chicago, IL, 3Rheumatology, Rush University Medical Center, Chicago, IL, 4Rush University Medical Center, Chicago, IL, 5Department of Nursing, Rush University Medical Center, Chicago, IL

    Background/Purpose: In patients with knee osteoarthritis (OA), synovitis is associated with severity of knee symptoms. Previously, we demonstrated that in patients undergoing partial meniscectomy without…
  • Abstract Number: 251 • 2013 ACR/ARHP Annual Meeting

    Physical Activity Is Associated With Reduced Incident Disability: Evidence From The Osteoarthritis Initiative

    Dorothy D. Dunlop1, Jing Song1, Pamela A. Semanik2, Leena Sharma2, Joan M. Bathon3, Charles Eaton4, Marc C. Hochberg5, Rebecca D. Jackson6, C. Kent Kwoh7, W, Jerry Mysiw6, Michael C. Nevitt8 and Rowland W. Chang1, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Northwestern University, Chicago, IL, 3Columbia University, New York, NY, 4Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Providence, RI, 5Medicine, University of Maryland School of Medicine, Baltimore, MD, 6Ohio State University, Columbus, OH, 7School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 8Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA

     Background/Purpose: Over 56 million people in the U.S. are classified as disabled.  Physical activity is a low cost, broadly applicable approach to improve cardiovascular fitness,…
  • Abstract Number: 232 • 2012 ACR/ARHP Annual Meeting

    The Natural History of Sporadic Inclusion Body Myositis – an Observational Longitudinal Study

    Pedro Machado1, Andrea Cortese1, Jasper Morrow1, Liz Dewar1, Andy Hiscock1, Adrian Miller1, Stefen Brady2, David Hilton-Jones2, Matt Parton1 and Michael G. Hanna1, 1MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, United Kingdom, 2Oxford Muscle and Nerve Centre, John Radcliffe Hospital, Oxford, United Kingdom

    Background/Purpose: Our aim was to assess prospectively the clinical features and functional impact of inclusion body myositis (IBM), to identify reliable outcome measures for future…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology